File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification

TitleHepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
Authors
KeywordsAntibody to hepatitis B core antigen
Antibody to tumor necrosis factor
Antigen CD20
Hematopoietic stem cell transplantation
Hepatitis B surface antigen
Hepatitis B virus
Occult
Rituximab
Issue Date2015
Citation
World Journal of Hepatology, 2015, v. 28, p. 825-830 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/214382
ISSN
2023 Impact Factor: 2.5
2023 SCImago Journal Rankings: 0.673
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSeto, WKW-
dc.date.accessioned2015-08-21T11:21:22Z-
dc.date.available2015-08-21T11:21:22Z-
dc.date.issued2015-
dc.identifier.citationWorld Journal of Hepatology, 2015, v. 28, p. 825-830-
dc.identifier.issn1948-5182-
dc.identifier.urihttp://hdl.handle.net/10722/214382-
dc.languageeng-
dc.relation.ispartofWorld Journal of Hepatology-
dc.subjectAntibody to hepatitis B core antigen-
dc.subjectAntibody to tumor necrosis factor-
dc.subjectAntigen CD20-
dc.subjectHematopoietic stem cell transplantation-
dc.subjectHepatitis B surface antigen-
dc.subjectHepatitis B virus-
dc.subjectOccult-
dc.subjectRituximab-
dc.titleHepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification-
dc.typeArticle-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.doi10.4254/wjh.v7.i6.825-
dc.identifier.pmcidPMC4411525-
dc.identifier.scopuseid_2-s2.0-84928941488-
dc.identifier.hkuros249601-
dc.identifier.volume28-
dc.identifier.spage825-
dc.identifier.epage830-
dc.identifier.isiWOS:000439190100002-
dc.identifier.issnl1948-5182-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats